 NORCROSS, Ga., Oct. 14, 2022 GLOBE NEWSWIRE -- Galectin Therapeutics Inc. NASDAQ: GALT, the leading developer of therapeutics that target galectin proteins, announced today the Company will be presenting at two upcoming conferences. 